Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs

Thumbnail
View/Open
Issue date
2005
Author
Ribas i Fortuny, Judit
Gómez Arbonés, Javier
Boix Torras, Jacint
Suggested citation
Ribas i Fortuny, Judit; Gómez Arbonés, Javier; Boix Torras, Jacint; . (2005) . Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs. European Journal of Pharmacology, 2005, vol. 524, num. 1-3, p. 49-52. https://doi.org/10.1016/j.ejphar.2005.09.021.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Olomoucine and Roscovitine are pharmacological inhibitors of cyclin-dependent kinases (CDK) displaying a promising profile as anticancer agents. Both compounds are effective inductors of apoptosis in a human neuroblastoma cell line, SH-SY5Y. The characterization of this process had suggested the involvement of an extrinsic pathway [Ribas, J., Boix, J., 2004. Cell differentiation, Caspase inhibition, and macromolecular synthesis blockage, but not Bcl-2 or Bcl-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs. Exp. Cell Res. 295 9<br>24.], which depends on either Caspase 8 or Caspase 10 activation. However, neither Caspase 8 nor Caspase 10 is expressed in SH- SY5Y cells because of gene silencing. Upon Olomoucine or Roscovitine treatment, no re-expression of Caspase 8 or Caspase 10 was found. Therefore, in SH-SY5Y cells, this type of drugs is not triggering a canonical, Caspase 8/10-mediated, extrinsic apoptotic pathway. © 2005 Elsevier B.V. All rights reserved.
URI
http://hdl.handle.net/10459.1/48115
DOI
https://doi.org/10.1016/j.ejphar.2005.09.021
Is part of
European Journal of Pharmacology, 2005, vol. 524, num. 1-3, p. 49-52
Collections